Compare Stocks: SRTS, STIM, FOCL, and ZJYL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FOCL FocalTherics	$4.15 -3.0%	$4.99	$1.75 ▼ $6.40	$160.62M	-0.07	78,728 shs	104,833 shs
SRTS Sensus Healthcare	$3.05 -2.2%	$3.11	$2.66 ▼ $5.49	$51.36M	1.13	37,076 shs	51,055 shs
STIM Neuronetics	$2.90 -2.4%	$2.55	$0.80 ▼ $3.44	$226.31M	1.16	1.26 million shs	1.12 million shs
ZJYL Jin Medical International	$1.99 +0.5%	$2.33	$1.53 ▼ $12.00	$155.30M	7.31	127,368 shs	7,965 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FOCL FocalTherics	-3.04%	+1.22%	-4.82%	-13.72%	+414,999,900.00%
SRTS Sensus Healthcare	-2.24%	-3.17%	+1.33%	+9.32%	-1.29%
STIM Neuronetics	-2.36%	-4.29%	-7.64%	+135.77%	+1.75%
ZJYL Jin Medical International	+0.51%	-3.86%	-35.39%	-19.76%	-83.02%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FOCL FocalTherics	$4.15 -3.0%	$4.99	$1.75 ▼ $6.40	$160.62M	-0.07	78,728 shs	104,833 shs
SRTS Sensus Healthcare	$3.05 -2.2%	$3.11	$2.66 ▼ $5.49	$51.36M	1.13	37,076 shs	51,055 shs
STIM Neuronetics	$2.90 -2.4%	$2.55	$0.80 ▼ $3.44	$226.31M	1.16	1.26 million shs	1.12 million shs
ZJYL Jin Medical International	$1.99 +0.5%	$2.33	$1.53 ▼ $12.00	$155.30M	7.31	127,368 shs	7,965 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FOCL FocalTherics	-3.04%	+1.22%	-4.82%	-13.72%	+414,999,900.00%
SRTS Sensus Healthcare	-2.24%	-3.17%	+1.33%	+9.32%	-1.29%
STIM Neuronetics	-2.36%	-4.29%	-7.64%	+135.77%	+1.75%
ZJYL Jin Medical International	+0.51%	-3.86%	-35.39%	-19.76%	-83.02%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FOCL FocalTherics	2.40	Hold	$7.75	86.75% Upside
SRTS Sensus Healthcare	2.50	Moderate Buy	$5.83	91.26% Upside
STIM Neuronetics	2.67	Moderate Buy	$4.67	60.92% Upside
ZJYL Jin Medical International	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest SRTS, STIM, FOCL, and ZJYL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/17/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.00
9/14/2026	STIM Neuronetics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/11/2026	STIM Neuronetics	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy
9/11/2026	STIM Neuronetics	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$5.00
9/9/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.00
8/25/2026	FOCL FocalTherics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$10.00
8/18/2026	SRTS Sensus Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (D-)
8/17/2026	FOCL FocalTherics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/17/2026	SRTS Sensus Healthcare	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/14/2026	SRTS Sensus Healthcare	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$4.50 ➝ $4.00
8/14/2026	FOCL FocalTherics	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$4.00

(Data available from 9/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FOCL FocalTherics	$70.53M	2.21	N/A	N/A	$0.52 per share	7.98
SRTS Sensus Healthcare	$27.48M	1.83	N/A	N/A	$2.93 per share	1.04
STIM Neuronetics	$149.16M	1.48	N/A	N/A	$0.38 per share	7.63
ZJYL Jin Medical International	$20.69M	7.54	$0.18 per share	10.81	$3.78 per share	0.53

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FOCL FocalTherics	-$29.25M	-$1.03	N/A	N/A	N/A	-56.26%	-248.00%	-44.69%	N/A
SRTS Sensus Healthcare	-$7.72M	-$0.94	N/A	N/A	N/A	-88.45%	-21.57%	-19.20%	11/5/2026 (Estimated)
STIM Neuronetics	-$39M	-$0.44	N/A	N/A	N/A	-19.62%	-125.11%	-22.15%	11/3/2026 (Estimated)
ZJYL Jin Medical International	$1.19M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest SRTS, STIM, FOCL, and ZJYL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	FOCL FocalTherics	-$0.20	-$0.39	-$0.19	-$0.39	N/A	$13.20 million
8/13/2026	Q2 2026	SRTS Sensus Healthcare	-$0.1250	-$0.53	-$0.4050	-$0.53	$4.60 million	$2.29 million
8/11/2026	Q2 2026	STIM Neuronetics	-$0.1230	-$0.05	+$0.0730	-$0.05	$40.17 million	$41.57 million
8/4/2026	Q2 2026	ZJYL Jin Medical International	N/A	-$0.01	N/A	-$0.0050	N/A	$4.46 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FOCL FocalTherics	N/A	N/A	N/A	N/A	N/A
SRTS Sensus Healthcare	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A
ZJYL Jin Medical International	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FOCL FocalTherics	1.79	1.60	1.38
SRTS Sensus Healthcare	N/A	8.71	4.30
STIM Neuronetics	2.84	1.88	1.69
ZJYL Jin Medical International	0.10	1.95	1.70

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FOCL FocalTherics	62.74%
SRTS Sensus Healthcare	25.30%
STIM Neuronetics	53.59%
ZJYL Jin Medical International	N/A

Insider Ownership

Company	Insider Ownership
FOCL FocalTherics	10.10%
SRTS Sensus Healthcare	10.20%
STIM Neuronetics	8.40%
ZJYL Jin Medical International	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FOCL FocalTherics	230	37.53 million	33.74 million	N/A
SRTS Sensus Healthcare	60	16.46 million	14.78 million	Optionable
STIM Neuronetics	658	76.20 million	69.80 million	Optionable
ZJYL Jin Medical International	273	78.43 million	N/A	Not Optionable

SRTS, STIM, FOCL, and ZJYL Headlines

Recent News About These Companies

Jin Medical International Ltd. (NASDAQ:ZJYL) Sees Significant Drop in Short Interest

September 13, 2026 | americanbankingnews.com

Jin Medical International to Acquire Control of Ginseng-Tech Assets via US$159 Million VIE Deal

September 8, 2026 | tipranks.com

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

August 27, 2026 | livemint.com

Jin Medical International Ltd. Class A

August 6, 2026 | edition.cnn.com

Jin Medical International (ZJYL) stock soars over 63% after hours: Here's what you need to know

August 5, 2026 | msn.com

Jin Medical International Completes VIE Deal and Expands Share Base in July 2026

August 4, 2026 | tipranks.com

JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results

August 4, 2026 | prnewswire.com

Jin Medical International

July 21, 2026 | fool.com

Jin Medical International Restructures Share Classes to Expand Super-Voting Control

July 20, 2026 | tipranks.com

Jin Medical International Earnings Estimates, EPS & Revenue | NASDAQ:ZJYL | Benzinga

July 12, 2026 | benzinga.com

Jin Medical International Ltd - Ordinary Shares - Class A

July 1, 2026 | money.usnews.com

Jin Medical Plans Major VIE Acquisition and Governance Restructuring Ahead of July 2026 EGM

June 29, 2026 | tipranks.com

Jin Medical International Replaces Audit Alliance With Enrome as Independent Auditor

June 4, 2026 | tipranks.com

Jin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share Split

April 10, 2026 | theglobeandmail.com

Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement

April 7, 2026 | prnewswire.com

Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative

March 11, 2026 | prnewswire.com

Jin Medical Shareholders Approve Dual-Class Structure and Conditional Reverse Splits

February 7, 2026 | theglobeandmail.com

Jin Medical CEO Fireside Chat

February 5, 2026 | prnewswire.com

Jin Medical to Host February 1 Fireside Chat as It Revamps Corporate Website

January 28, 2026 | tipranks.com

Jin Medical International Ltd. To Host Management Fireside Chat

January 26, 2026 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SRTS, STIM, FOCL, and ZJYL Company Descriptions

FocalTherics NASDAQ:FOCL

$4.15 -0.13 (-3.04%)

As of 09/18/2026 04:00 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Sensus Healthcare NASDAQ:SRTS

$3.05 -0.07 (-2.24%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$3.05 0.00 (0.00%)

As of 09/18/2026 04:10 PM Eastern

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Neuronetics NASDAQ:STIM

$2.90 -0.07 (-2.36%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$2.89 -0.01 (-0.45%)

As of 09/18/2026 07:55 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Jin Medical International NASDAQ:ZJYL

$1.99 +0.01 (+0.51%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$1.93 -0.06 (-3.02%)

As of 09/18/2026 07:55 PM Eastern

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SRTS, STIM, FOCL, and ZJYL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SRTS, STIM, FOCL, and ZJYL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SRTS, STIM, FOCL, and ZJYL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SRTS, STIM, FOCL, and ZJYL Company Descriptions

FocalTherics NASDAQ:FOCL

Sensus Healthcare NASDAQ:SRTS

Neuronetics NASDAQ:STIM

Jin Medical International NASDAQ:ZJYL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SRTS, STIM, FOCL, and ZJYL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SRTS, STIM, FOCL, and ZJYL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SRTS, STIM, FOCL, and ZJYL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SRTS, STIM, FOCL, and ZJYL Company Descriptions

FocalTherics NASDAQ:FOCL

Sensus Healthcare NASDAQ:SRTS

Neuronetics NASDAQ:STIM

Jin Medical International NASDAQ:ZJYL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools